We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $4.05B
1-Year Est. Return 19.01%
This Fund
S&P 500
This Quarter Est. Return
+10.49%
1 Year Est. Return
+19.01%
3 Year Est. Return
+47.13%
5 Year Est. Return
+48.95%
10 Year Est. Return
+147.53%
AUM
$4.05B
AUM Growth
+$540M
Cap. Flow
+$201M
Cap. Flow %
4.95%
Top 10 Hldgs %
64.21%
Holding
413
New
75
Increased
186
Reduced
86
Closed
13

Sector Composition

Rank Sector Weight
1 Miscellaneous 90.27%
2 Technology 3.64%
3 Financials 2.01%
4 Communication Services 1.23%
5 Healthcare 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DFAS icon
51
Dimensional US Small Cap ETF
DFAS
$15.6B
$9.33M 0.23%
113,295
-1,639
-1% -$127K
IWD icon
52
iShares Russell 1000 Value ETF
IWD
$84.7B
$8.9M 0.22%
36,690
+169
+0.5% +$39.4K
JPM icon
53
JPMorgan Chase
JPM
$962B
$8.84M 0.22%
27,003
+1,579
+6% +$490K
EFA icon
54
iShares MSCI EAFE ETF
EFA
$80B
$8.6M 0.21%
82,823
-2,826
-3% -$291K
IWV icon
55
iShares Russell 3000 ETF
IWV
$20.4B
$8.38M 0.21%
19,662
-195
-1% -$80.3K
DSI icon
56
iShares MSCI KLD 400 Social ETF
DSI
$5.56B
$7.83M 0.19%
54,986
+140
+0.3% +$19.2K
AMZN icon
57
Amazon
AMZN
$2.79T
$7.81M 0.19%
32,755
+4,029
+14% +$1.01M
VONV icon
58
Vanguard Russell 1000 Value ETF
VONV
$22.1B
$7.7M 0.19%
72,474
+174
+0.2% +$17.8K
USMV icon
59
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
$7.62M 0.19%
79,030
-4,071
-5% -$386K
QAI icon
60
NYLIM Hedge Multi-Strategy Tracker ETF
QAI
$1.02B
$7.59M 0.19%
207,334
+10,512
+5% +$377K
NVDA icon
61
NVIDIA
NVDA
$5.52T
$7.22M 0.18%
36,069
-11,515
-24% -$2.37M
MNA icon
62
NYLIM Merger Arbitrage ETF
MNA
$257M
$6.64M 0.16%
181,887
+11,672
+7% +$425K
QQQ icon
63
Invesco QQQ Trust
QQQ
$488B
$6.6M 0.16%
8,957
+730
+9% +$502K
ITOT icon
64
iShares Core S&P Total US Stock Market ETF
ITOT
$97.9B
$6.43M 0.16%
39,120
-1,115
-3% -$177K
VUG icon
65
Vanguard Morningstar Growth ETF
VUG
$229B
$6.28M 0.16%
72,881
-1,123
-2% -$94.5K
SUSA icon
66
iShares ESG Optimized MSCI USA ETF
SUSA
$4.14B
$6.25M 0.15%
40,507
-1,500
-4% -$221K
RY icon
67
Royal Bank of Canada
RY
$294B
$6.06M 0.15%
29,286
+946
+3% +$176K
SCHX icon
68
Schwab US Large- Cap ETF
SCHX
$74.7B
$5.73M 0.14%
194,663
+281
+0.1% +$8.02K
VUSB icon
69
Vanguard Ultra-Short Bond ETF
VUSB
$9.31B
$5.73M 0.14%
115,081
+29,476
+34% +$1.47M
META icon
70
Meta Platforms (Facebook)
META
$1.56T
$5.73M 0.14%
10,170
+637
+7% +$390K
IYY icon
71
iShares Dow Jones US ETF
IYY
$3.07B
$5.42M 0.13%
29,744
IUSG icon
72
iShares Core S&P US Growth ETF
IUSG
$33.5B
$5.32M 0.13%
28,293
+506
+2% +$91.4K
VV icon
73
Vanguard Morningstar Large-Cap ETF
VV
$54.5B
$5.1M 0.13%
14,815
+367
+3% +$122K
JNJ icon
74
Johnson & Johnson
JNJ
$671B
$5.08M 0.13%
19,981
-639
-3% -$149K
EFAV icon
75
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.57B
$4.87M 0.12%
55,558
-299
-0.5% -$27.1K

Similar funds

Aspiriant LLC's Q2 2026 Portfolio in Review

As of Q2 2026, Aspiriant LLC held 413 positions worth $4.05B, up 15% from $3.51B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Aspiriant LLC deployed $201M of net new capital in Q2 2026, opening 75 new positions and adding to 186 existing holdings. Its largest new stake was Eagle Capital Select Equity ETF: 58,062 shares worth $1.87M.

By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 91% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $2.37M trimmed.

  • Aspiriant LLC's largest Q2 2026 buy was Eagle Capital Select Equity ETF: 58,062 shares worth $1.87M.
  • Aspiriant LLC added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $145M increase.
  • Aspiriant LLC's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $2.37M.
  • Aspiriant LLC fully exited Vanguard Short-Term Inflation-Protected Securities Index Fund in Q2 2026, selling an estimated $4.1M.
  • Aspiriant LLC's ten largest holdings make up 64% of its $4.05B portfolio in Q2 2026.
  • Aspiriant LLC opened 75 new positions and closed 13 in Q2 2026.
  • Aspiriant LLC's portfolio value rose 15% quarter-over-quarter to $4.05B.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.